Kenvue’s Tylenol® Earns FDA Approval for OTC Naproxen Combination
SUMMIT, N.J., July 24, 2026x Tylenol®, a flagship pain relief brand from Kenvue, has received U.S. Food and Drug...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SUMMIT, N.J., July 24, 2026x Tylenol®, a flagship pain relief brand from Kenvue, has received U.S. Food and Drug...
BRISTOL, Tenn., Feb. 5, 2026 — Kingsway Pharmaceuticals, LLC announced the acquisition of the Lobe Miracle® brand from CCA...
Boucherville, Quebec | December 23, 2025 — LSL Pharma Group Inc., a Canadian integrated pharmaceutical company, announced the successful...
